MULTIMODAL IMAGING IN A CASE OF DEFEROXAMINE-INDUCED MACULOPATHY
- 1 January 2014
- journal article
- case report
- Published by Wolters Kluwer Health in RETINAL Cases & Brief Reports
- Vol. 8 (4) , 306-309
Abstract
Purpose: To report a case of deferoxamine-induced maculopathy and present the use of multimodal retinal imaging to study this disease entity. Methods: This is an observational case report of one patient. Multimodal imaging with fundus autofluorescence, infrared imaging, and spectral domain optical coherence tomography was used to investigate the macular changes induced by deferoxamine toxicity. Results: A 53-year-old man with history of β-thalassemia presented with decreased vision in both eyes 1 month after initiating deferoxamine therapy. Infrared imaging showed areas of increased stippled infrared intensity through the macula. Fundus autofluorescence revealed diffuse areas of stippled hyperautofluorescence and hypoautofluorescence. Spectral domain optical coherence tomography changes included disruption of the ellipsoid zone, attenuation of the photoreceptors, and deposits within the retinal pigment epithelium. Conclusion: A case of deferoxamine-induced maculopathy was described and the use of multimodal retinal imaging to study this disease entity was presented.Keywords
This publication has 6 references indexed in Scilit:
- Macular vitelliform lesion in desferrioxamine-related retinopathyDocumenta Ophthalmologica, 2010
- BILATERAL VITELLIFORM MACULOPATHY AND DEFEROXAMINE TOXICITYRetina, 2004
- Bull's eye maculopathy with deferoxamineEuropean Journal of Haematology, 2003
- The expanded clinical spectrum of deferoxamine retinopathy11The authors have no commercial or proprietary interest in any of the materials noted in this article.Ophthalmology, 2002
- Ocular toxicity of desferrioxamine: light microscopic histochemical and ultrastructural findings.British Journal of Ophthalmology, 1986
- Transfusion Haemosiderosis and Chelation TherapyClinics in Haematology, 1982